These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1505975)

  • 1. De novo splice site mutation in the antithrombin III (AT3) gene causing recurrent venous thrombosis: demonstration of exon skipping by ectopic transcript analysis.
    Berg LP; Grundy CB; Thomas F; Millar DS; Green PJ; Slomski R; Reiss J; Kakkar VV; Cooper DN
    Genomics; 1992 Aug; 13(4):1359-61. PubMed ID: 1505975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation.
    Jochmans K; Lissens W; Yin T; Michiels JJ; van der Luit L; Peerlinck K; De Waele M; Liebaers I
    Blood; 1994 Dec; 84(11):3742-8. PubMed ID: 7949130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.
    Millar DS; Wacey AI; Ribando J; Melissari E; Laursen B; Woods P; Kakkar VV; Cooper DN
    Hum Genet; 1994 Nov; 94(5):509-12. PubMed ID: 7959685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation (E113X) of antithrombin III gene (AT3) in a woman with gestational recurrent thrombosis.
    Yamada H; Hoshi N; Kato EH; Ebina Y; Kishida T; Sagawa T; Matsuno K; Fujimoto S
    Am J Med Genet; 2000 Apr; 91(5):348-50. PubMed ID: 10766996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice site mutation in the human protein C gene associated with venous thrombosis: demonstration of exon skipping by ectopic transcript analysis.
    Lind B; van Solinge WW; Schwartz M; Thorsen S
    Blood; 1993 Oct; 82(8):2423-32. PubMed ID: 8400292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis.
    Binder G; Ranke MB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1247-52. PubMed ID: 7714096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for mutations in the antithrombin III gene causing recurrent venous thrombosis by single-strand conformation polymorphism analysis.
    Millar DS; Lopez A; White D; Abraham G; Laursen B; Holding S; Reverter JC; Reynaud J; Martinowitz U; Hayes JP
    Hum Mutat; 1993; 2(4):324-6. PubMed ID: 8401542
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel missense mutation in the antithrombin III gene (Ala387-->Val) causing recurrent venous thrombosis.
    White D; Abraham G; Carter C; Kakkar VV; Cooper DN
    Hum Genet; 1992 Dec; 90(4):472-3. PubMed ID: 1483709
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel nonsense mutation in the antithrombin III gene (Cys-4-->stop) causing recurrent venous thrombosis.
    Saleun S; De Moerloose P; Bura A; Aiach M; Emmerich J
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):578-9. PubMed ID: 8874869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
    Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
    Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE; Conney AH; Wei SJ
    Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy.
    Formstone CJ; Wacey AI; Berg LP; Rahman S; Bevan D; Rowley M; Voke J; Bernardi F; Legnani C; Simioni P; Girolami A; Tuddenham EG; Kakkar VV; Cooper DN
    Blood; 1995 Oct; 86(7):2632-41. PubMed ID: 7545463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic transcript analysis in human antithrombin deficiency.
    Perry DJ
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):531-6. PubMed ID: 7578894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation in the antithrombin III gene (Ser349----Pro) causing recurrent venous thrombosis.
    Grundy CB; Holding S; Millar DS; Kakkar VV; Cooper DN
    Hum Genet; 1992 Mar; 88(6):707-8. PubMed ID: 1551681
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing.
    Olds RJ; Lane DA; Caso R; Girolami A; Thein SL
    Nucleic Acids Res; 1990 Apr; 18(7):1926. PubMed ID: 2336381
    [No Abstract]   [Full Text] [Related]  

  • 17. A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
    Olds RJ; Lane DA; Finazzi G; Barbui T; Thein SL
    Blood; 1990 Dec; 76(11):2182-6. PubMed ID: 1979501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent deletion in the human antithrombin III gene.
    Grundy CB; Thomas F; Millar DS; Krawczak M; Melissari E; Lindo V; Moffat E; Kakkar VV; Cooper DN
    Blood; 1991 Aug; 78(4):1027-32. PubMed ID: 1868237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel exonic mutation at -13 from 5' splice site causing exon skipping in a girl with mitochondrial acetoacetyl-coenzyme A thiolase deficiency.
    Fukao T; Yamaguchi S; Wakazono A; Orii T; Hoganson G; Hashimoto T
    J Clin Invest; 1994 Mar; 93(3):1035-41. PubMed ID: 7907600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
    Molho-Sabatier P; Aiach M; Gaillard I; Fiessinger JN; Fischer AM; Chadeuf G; Clauser E
    J Clin Invest; 1989 Oct; 84(4):1236-42. PubMed ID: 2794060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.